Table 2 Factors associated with undesirable screening^a for tuberculosis among PLHIV in the AMPATH programme, Kenya (2015–2016)

 Female

(43.8)

1

1

 Male

(44.4)

1.01 (0.99–1.03)

0.99 (0.98–1.01)

 35–44

(42.8)

1

1

 0–4

(38.8)

0.91 (0.88–0.94)

0.93 (0.87–0.99)

 5–9

(49.1)

1.15 (1.11–1.19)

0.99 (0.93–1.05)

 10–19

(59.4)

1.39 (1.35–1.42)

1.05 (1.00–1.11)

 20–24

(35.1)

0.82 (0.78–0.87)

0.92 (0.87–0.96)

 25–34

(36.1)

0.84 (0.82–0.86)

0.93 (0.90–0.95)

 45–54

(47.5)

1.11 (1.09–1.13)

1.07 (1.05–1.09)

 55–64

(46.5)

1.09 (1.06–1.11)

1.04 (1.01–1.06)

 65+

(45.5)

1.06 (1.02–1.11)

1.00 (0.96–1.05)

 Adults clinics

(43.4)

1

1

 Paediatric clinics

(49.5)

1.14 (1.12–1.16)

1.27 (1.20–1.34)

 Youth clinics

(32.9)

0.76 (0.66–0.88)

0.80 (0.67–0.94)

 PMTCT clinics

(36.9)

0.85 (0.82–0.89)

0.89 (0.85–0.92)

 Not on ART

(39.1)

1

1

 On ART

(47.6)

1.22 (1.19–1.24)

1.16 (1.13–1.18)

Total encounters

1.05 (1.04–1.05)

1.04 (1.04–1.04)

 High volume (pts)

(44.5)

1

1

 Medium volume (pts)

(42.7)

0.96 (0.94–0.98)

0.92 (0.90–0.94)

 Low volume (pts)

(36.1)

0.81 (0.77–0.86)

0.85 (0.80–0.89)

 Very low volume (pts)

(33.9)

0.76 (0.68–0.86)

0.94 (0.84–1.04)